Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

092024-12

Documents on Display--circular
092024-12

Documents on Display--the written consent of Kingsway Capital Limited referred
092024-12

Documents on Display--the letter from the Independent Financial Adviser
092024-12

Documents on Display--the letter from the Independent Board Committee
092024-12

Documents on Display--New Framework Purchase Agreement
092024-12

Documents on Display--New Framework Sales Agreement
092024-12

FORM OF PROXY FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON 27 DECEMBER 2024 OR AT ANY ADJOURNMENT THEREOF
092024-12

NOTICE OF EXTRAORDINARY GENERAL MEETING
092024-12

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK SALES AGREEMENT AND FRAMEWORK PURCHASE AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETING
022024-12

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
292024-11

DELAY IN DESPATCH OF CIRCULAR
082024-11

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK SALES AGREEMENT AND FRAMEWORK PURCHASE AGREEMENT

1 2 3 4 5

The Enterprise OA